{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:45:28Z","timestamp":1761630328327,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":6922,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1046\/j.1600-6135.2003.00272.x","type":"journal-article","created":{"date-parts":[[2003,12,15]],"date-time":"2003-12-15T03:54:43Z","timestamp":1071460483000},"page":"31-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Earlier Low-Dose TBI or DST Overcomes CD8+ T-Cell-Mediated Alloresistance to Allogeneic Marrow in Recipients of Anti-CD40L"],"prefix":"10.1016","volume":"4","author":[{"given":"Yasuo","family":"Takeuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Wekerle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1600-6135.2003.00272.x_bib1","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0952-7915(97)80042-8","article-title":"Bone marrow chimerism and transplantation tolerance","volume":"9","author":"Nikolic","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1084\/jem.169.2.493","article-title":"Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen","volume":"169","author":"Sharabi","year":"1989","journal-title":"J Exp Med"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib3","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1182\/blood.V83.4.939.939","article-title":"Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow","volume":"83","author":"Tomita","year":"1994","journal-title":"Blood"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00007890-199602150-00027","article-title":"Additional mAb injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mAbs and 3 Gy whole body irradiation","volume":"61","author":"Tomita","year":"1996","journal-title":"Transplantation"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib5","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1084\/jem.187.12.2037","article-title":"Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance","volume":"187","author":"Wekerle","year":"1998","journal-title":"J Exp Med"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/74731","article-title":"Allogeneic bone marrow transplantation with costimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment","volume":"6","author":"Wekerle","year":"2000","journal-title":"Nature Med"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.165.1.1","article-title":"Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning","volume":"165","author":"Durham","year":"2000","journal-title":"J Immunol"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib8","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.4049\/jimmunol.166.5.2970","article-title":"CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40\u2013CD40L interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway","volume":"166","author":"Ito","year":"2001","journal-title":"J Immunol"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1600-065X.1997.tb01030.x","article-title":"Thymic aging and T-cell regeneration","volume":"160","author":"Mackall","year":"1997","journal-title":"Immunol Rev"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib10","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1182\/blood.V89.10.3700","article-title":"Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy","volume":"89","author":"Mackall","year":"1997","journal-title":"Blood"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1084\/jem.171.3.645","article-title":"In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment","volume":"171","author":"Sykes","year":"1990","journal-title":"J Exp Med"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1084\/jem.150.3.580","article-title":"Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors","volume":"150","author":"Unkeless","year":"1979","journal-title":"J Exp Med"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nm0797-783","article-title":"Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning","volume":"3","author":"Sykes","year":"1997","journal-title":"Nature Med"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib14","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1172\/JCI2703","article-title":"Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4+ T cells, Interferon-\u03b3, and CTLA4","volume":"101","author":"Markees","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00007890-199707270-00026","article-title":"Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand","volume":"64","author":"Markees","year":"1997","journal-title":"Transplantation"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1034\/j.1600-6143.2001.10409.x","article-title":"Mechanisms involved in the establishment of tolerance through costimulatory blockade and BMT. Lack of requirement for CD40L-mediated signaling for tolerance or deletion of donor-reactive CD4+ cells","volume":"1","author":"Kurtz","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib17","series-title":"Progress in Immunology VIII. Proceedings of the Eighth International Congress of Immunology, Budapest, 1992. Heidelberg :","article-title":"T cell subsets resisting induction of mixed chimerism across various histocompatibility barriers.","author":"Sharabi","year":"1992"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1053\/bbmt.2001.v7.pm11302548","article-title":"Induction of tolerance by mixed chimerism with nonmyeloablative host conditioning: the importance of overcoming intrathymic alloresistance","volume":"7","author":"Nikolic","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib19","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1172\/JCI8082","article-title":"Asialo GM1+ CD8+ T cells play a critical role in costimulation blockade-resistant allograft rejection","volume":"104","author":"Tramblay","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib20","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.4049\/jimmunol.163.5.2358","article-title":"Blockade of the CD28\/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells","volume":"163","author":"Newell","year":"1999","journal-title":"J Immunol"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib21","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4049\/jimmunol.165.2.1111","article-title":"CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection","volume":"165","author":"Jones","year":"2000","journal-title":"J Immunol"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib22","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.4049\/jimmunol.163.9.4805","article-title":"CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression","volume":"163","author":"Honey","year":"1999","journal-title":"J Immunol"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib23","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.4049\/jimmunol.167.2.1103","article-title":"Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression","volume":"167","author":"Adams","year":"2001","journal-title":"J Immunol"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1365-2141.2002.03801.x","article-title":"H2-mismatched transplantation with repetitive cell infusions and CD40 ligand antibody infusions without myeloablation","volume":"119","author":"Lambert","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood.V98.2.467","article-title":"Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions","volume":"98","author":"Taylor","year":"2001","journal-title":"Blood"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib26","doi-asserted-by":"crossref","first-page":"9560","DOI":"10.1073\/pnas.92.21.9560","article-title":"Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand","volume":"92","author":"Parker","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib27","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.4049\/jimmunol.161.10.5331","article-title":"The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo","volume":"161","author":"Niimi","year":"1998","journal-title":"J Immunol"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.4049\/jimmunol.164.1.512","article-title":"Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner","volume":"164","author":"Iwakoshi","year":"2000","journal-title":"J Immunol"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib29","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.4049\/jimmunol.167.11.6623","article-title":"Skin allograft maintenance in a new synchimeric model system of tolerance","volume":"167","author":"Iwakoshi","year":"2001","journal-title":"J Immunol"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib30","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1182\/blood-2002-10-3014","article-title":"The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulatory blockade","volume":"101","author":"Blaha","year":"2002","journal-title":"Blood"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib31","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/30989","article-title":"A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell","volume":"393","author":"Ridge","year":"1998","journal-title":"Nature"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib32","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/30996","article-title":"Help for cytotoxic T-cell responses is mediated by CD40 signaling","volume":"393","author":"Bennertt","year":"1998","journal-title":"Nature"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib33","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/31002","article-title":"T-cell help for cytotoxic T lympohcytes is mediated by CD40\u2013CD40L interactions","volume":"393","author":"Schoenberger","year":"1998","journal-title":"Nature"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib34","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1128\/jvi.70.12.8375-8381.1996","article-title":"CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection","volume":"70","author":"Whitmire","year":"1996","journal-title":"J Virol"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib35","doi-asserted-by":"crossref","first-page":"723","DOI":"10.4049\/jimmunol.163.2.723","article-title":"Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens","volume":"163","author":"Morgan","year":"1999","journal-title":"J Immunol"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1084\/jem.188.2.409","article-title":"Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction","volume":"188","author":"Kurts","year":"1998","journal-title":"J Exp Med"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1084\/jem.191.3.541","article-title":"CD40-independent pathways of T cell help for priming of CD8+ cytotoxic T lymphocytes","volume":"191","author":"Lu","year":"2000","journal-title":"J Exp Med"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib38","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.4049\/jimmunol.158.6.2919","article-title":"Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells","volume":"158","author":"Verhasselt","year":"1997","journal-title":"J Immunol"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib39","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0167-5699(98)01427-3","article-title":"Coordinated events during bacteria-induced DC maturation","volume":"20","author":"Rescigno","year":"1999","journal-title":"Immunol Today"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1084\/jem.189.2.371","article-title":"Fc\u03b3 receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization","volume":"189","author":"Regnault","year":"1999","journal-title":"J Exp Med"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib41","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1084\/jem.185.12.2089","article-title":"T cell stimulation in vivo by lipopolysaccharide (LPS)","volume":"185","author":"Tough","year":"1997","journal-title":"J Exp Med"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib42","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1099\/0022-1317-68-8-2203","article-title":"Studies on the expression of spontaneous and induced interferons in mouse peritoneal macrophages by means of monoclonal antibodies to mouse interferons","volume":"68","author":"Belardelli","year":"1987","journal-title":"J Gen Virol"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib43","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1182\/blood.V84.12.4008.bloodjournal84124008","article-title":"Interleukin-12. A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes","volume":"84","author":"Trinchieri","year":"1994","journal-title":"Blood"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib44","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.4049\/jimmunol.164.8.4220","article-title":"Type I IFN modulates innate and specific antiviral immunity","volume":"164","author":"Durbin","year":"2000","journal-title":"J Immunol"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib45","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.4049\/jimmunol.164.3.1216","article-title":"Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells","volume":"164","author":"Wang","year":"2000","journal-title":"J Immunol"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib46","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1182\/blood.V83.8.2360.2360","article-title":"Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice","volume":"83","author":"Xun","year":"1994","journal-title":"Blood"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib47","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1172\/JCI0214989","article-title":"Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease","volume":"109","author":"Zhang","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib48","first-page":"115","article-title":"Experimental manipulations and marrow-derived factors which affect the outcome of bone marrow transplantation across the H\u20132 barrier in lethally irradiated mice","volume":"16","author":"Pierpaoli","year":"1985","journal-title":"J Clin Lab Immunol"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000046514","article-title":"Increased expression of Fas (APO-1, CD95) on CD4+ and CD8+ T lymphocytes during total body irradiation","volume":"104","author":"Fujimori","year":"2000","journal-title":"Acta Haematologic"},{"key":"10.1046\/j.1600-6135.2003.00272.x_bib50","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.4049\/jimmunol.169.10.5401","article-title":"Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy","volume":"169","author":"Van Maurik","year":"2002","journal-title":"J Immunol"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1600-6135.2003.00272.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522071386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522071386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:30:35Z","timestamp":1761625835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522071386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S1600613522071386"],"URL":"https:\/\/doi.org\/10.1046\/j.1600-6135.2003.00272.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"type":"print","value":"1600-6135"}],"subject":[],"published":{"date-parts":[[2004,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Earlier Low-Dose TBI or DST Overcomes CD8+ T-Cell-Mediated Alloresistance to Allogeneic Marrow in Recipients of Anti-CD40L","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1046\/j.1600-6135.2003.00272.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}